Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments | Market Insights | US | 2022

In 2020, the procedure deferrals due to the COVID-19 pandemic severely impacted the US open surgery instrument market. However, the overall market for open surgery devices in the US will exhibit moderate growth over the forecast period, driven largely by rising penetration of direct energy and closure devices in open procedures as well as the increasing adoption of premium-priced products although rising laparoscopic procedure penetration—and consequently declining open procedure volumes—will hamper market expansion.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for open surgery instruments in the US across an 11-year period.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…
Report
Laparoscopic Devices – Market Insights – Europe
Laparoscopic procedure volumes in Europe will grow only modestly through 2034, with notable variation across procedure types. Bariatric and colorectal laparoscopic surgeries are expected to…
Report
Laparoscopic Surgical Robotic Devices – Market Insights – Global
The laparoscopic surgical robotic device market is expanding rapidly as adoption broadens beyond traditional segments and sites of care. Growth is driven by increasing robotic penetration in…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…